Blood marker hunt could prevent immunotherapy harm
NCT ID NCT07249060
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study aims to find a way to predict serious side effects from cancer immunotherapy. Researchers will measure substances called interferons in the blood of 300 cancer patients starting immunotherapy and 40 people with autoimmune diseases like lupus. By comparing these groups, they hope to identify early warning signs that could help doctors prevent or manage side effects in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.